20435 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR
#302POWDER FORMULATIONS FOR INHALATION CONTAINING ENANTIOMERICALLY PURE BETA-AGONISTS
#303Micronized tanaproget, compositions, and methods of preparing the same
#304MICROORGANISM-KILLING COMBINATION
#305Aerosol fluoroquinolone formulations for improved pharmacokinetics
#306Topical use of Levofloxacin for reducing lung inflammation
#307Matrix metalloproteinase inhibitors
#308HETEROCYCLIDENE-N-(ARYL) ACETAMIDE DERIVATIVE
#309AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS
#310Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
#311Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases
#312ANTI-AMNESIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
#313Cyclothiocarbamate derivatives as progesterone receptor modulators
#314Antituberculous composition comprising oxazole compounds
#315Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#316Solid preparation
#317Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
#318Methods and systems for molecular inhibition
#319METHODS AND COMPOSITIONS FOR CONTROLLING THE BIOAVAILABILITY OF POORLY SOLUBLE DRUGS
#320Methods and systems for treating disease
#321Methods and systems for treating disease
#322Methods and systems for molecular inhibition
#323METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS
#324Pharmaceutical Combination
#325Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
#326VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
#327Drug Combination Therapy and Pharmaceutical Compositions for Treating Inflammatory Disorders
#328UPREGULATING BDNF LEVELS TO MITIGATE MENTAL RETARDATION
#329COMBINATION THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
#330METHODS OF TREATING ESTROGEN-RESPONSIVE CONDITIONS BY ORPHAN NUCLEAR RECEPTOR ACTIVATION
#331AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS
#332PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
#333Methods and systems for treating disease
#334Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes
#335Methods and systems for molecular inhibition
#336Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
#337Neurotherapeutic composition and method therefor
#338Novel heterocyclic compound
#339Neuroprotective compounds and pharmaceutical compositions comprising them
#340Use of cathepsin s inhibitors for treating an immune response caused by administration of a small molecule therapeutic or biologic
#341Unitary pharmaceutical dosage form
#342Aerosol formulations for the inhalation of beta-agonists
#343Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
#344Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
#345Amorphous efavirenz and the production thereof
#346Pharmaceutical composition for the prevention or treatment of cerebral oedemas
#347Use of non-steroidal progesterone receptor modulators
#348Tanaproget compositions containing ethinyl estradiol
#349Method of treating cognitive decline due to sleep deprivation and stress
#350Use of heterocyclic compounds as SCCE inhibitors
#351Compositions containing micronized tanaproget prepared by wet granulation
#352Micronized tanaproget, compositions, and methods of preparing the same
#353Micronized tanaproget and compositions containing same
#354Methods and compositions for the treatment of diseases of the eye
#355Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#356Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#357Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis
#358Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation
#359Cyclothiocarbamate derivatives as progesterone receptor modulators
#360Nonsteroidal antiinflammatory agents
#361Progesterone receptor antagonists, contraceptive regimens, and kits
#362Cyclic progestin regimens and kits
#363Combination therapy
#364Topical formulations for treating allergic diseases
#365Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
#366Phenoxyalkylamine derivatives useful as opioid delta receptor ligands
#367Indole compounds and medicinal use thereof
#368Medicament for preventing and/or treating dry eye
#369Nanodiamond compositions and their use for drug delivery